Learn how erenumab, a CGRP receptor–blocking monoclonal antibody, is transforming migraine prevention. Discover its mechanism, benefits for episodic and chronic migraine, and why it outperforms many traditional oral preventives.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs